Delivery Order SPE2DB22D2214-SPE2DB24FS5JF
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BOTOX 200 unit vials to the U.S. government. The $6,985.56 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of BOTOX 200 UNIT VIALS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,328.52 and an ultimate completion date of July 10, 2024. It is a firm-fixed-price Delivery Order contract, without a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of BOTOX 200 UNIT VIALS to the U.S. government. The contract, with a ceiling value of $2,910.65, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award IDC, valued up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,910.65 Firm Fixed Price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 200-unit vials of BOTOX. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between DLA Troop Support Medical and Amerisourcebergen, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Botox 200 unit vials to the U.S. government. The contract, valued at $11,642.60, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal government, holding a $999,999,999.00 Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of BOTOX 200 unit vials to the U.S. government. The $8,731.95 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Medical Supply Chain, which is part of the Department of Defense. The award is not associated with a set-aside program. Amerisourcebergen, one of the largest pharmaceutical distribution companies, holds a $999,999,999.00 Indefinite Delivery Contract...
- This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA). The contract has a ceiling value of $5,821.30 and a completion date of May 16, 2024. It is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,564,937,808 units of Botox 200 unit vials. The contract has a ceiling value of $2,328.52 and is a delivery order contract with a firm fixed price pricing type. The awarding agency is the Defense Logistics Agency (DLA) Troop Support Medical, a major acquisition command within the Department of Defense (DoD) that provides pharmaceuticals and medical supplies to military treatment...
- This federal contract award is for the delivery of BOTOX 200 unit vials to the U.S. Department of Defense (DoD) through the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $23,285.20, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 200-unit vials of the pharmaceutical product BOTOX. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,328.52 and an ultimate completion date of May 7, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB24FS5JFDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 200 unit vials of BOTOX to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award has a ceiling value of $13,971.12 and is structured as a firm-fixed-price delivery order, without any set-aside designation. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company has also been awarded a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 6/12/24 |